郭晓庆, 李淑敏, 于晗, 叶建桥, 齐冬梅, 蒋海强, 齐于辰. 基于下丘脑代谢组学研究三子养亲汤干预正常高值血压痰湿壅盛证大鼠作用机制J. 药学学报, 2022, 57(11): 3387-3395. DOI: 10.16438/j.0513-4870.2022-0732
引用本文: 郭晓庆, 李淑敏, 于晗, 叶建桥, 齐冬梅, 蒋海强, 齐于辰. 基于下丘脑代谢组学研究三子养亲汤干预正常高值血压痰湿壅盛证大鼠作用机制J. 药学学报, 2022, 57(11): 3387-3395. DOI: 10.16438/j.0513-4870.2022-0732
GUO Xiao-qing, LI Shu-min, YU Han, YE Jian-qiao, QI Dong-mei, JIANG Hai-qiang, QI Yu-chen. Mechanism of Sanzi Yangqin decoction to prevent the development of prehypertension and excessive phlegm-dampness syndrome in rats based on hypothalamic metabonomicsJ. Acta Pharmaceutica Sinica, 2022, 57(11): 3387-3395. DOI: 10.16438/j.0513-4870.2022-0732
Citation: GUO Xiao-qing, LI Shu-min, YU Han, YE Jian-qiao, QI Dong-mei, JIANG Hai-qiang, QI Yu-chen. Mechanism of Sanzi Yangqin decoction to prevent the development of prehypertension and excessive phlegm-dampness syndrome in rats based on hypothalamic metabonomicsJ. Acta Pharmaceutica Sinica, 2022, 57(11): 3387-3395. DOI: 10.16438/j.0513-4870.2022-0732

基于下丘脑代谢组学研究三子养亲汤干预正常高值血压痰湿壅盛证大鼠作用机制

Mechanism of Sanzi Yangqin decoction to prevent the development of prehypertension and excessive phlegm-dampness syndrome in rats based on hypothalamic metabonomics

  • 摘要: 本实验旨在从下丘脑代谢组学角度探讨三子养亲汤(Sanzi Yangqin decoction, SYD)干预正常高值血压痰湿壅盛证大鼠的作用机制。将WKY大鼠随机分为正常组、模型组和SYD组。采用高脂+ 高盐方式制备正常高值血压痰湿壅盛证大鼠模型, 不同剂量SYD干预模型大鼠8周, 测量各组大鼠饮食量、体重、身长、血脂及血压, 利用液质联用技术分析筛选各组大鼠下丘脑中差异代谢物, 并进行代谢通路分析。结果显示, 与模型组相比较, SYD组大鼠饮食量减少, 体重降低, 血脂血压显著下降。同时下丘脑14个差异代谢物发生回调, 主要与氨基酸代谢、谷胱甘肽代谢、鞘脂代谢和甘油酯代谢有关, 提示SYD可能通过调节下丘脑饮食行为, 进而影响氨基酸代谢与能量代谢来发挥干预作用。本研究已获得山东中医药大学动物伦理审查委员会批准(批准号: SDUTCM20211103001)。

     

    Abstract: The purpose of this study was to explore the mechanism of Sanzi Yangqin decoction (SYD) from the perspective of hypothalamic metabonomics to prevent the development of prehypertension (PHT) and excessive phlegm-dampness syndrome in rats. WKY rats were randomly divided into a normal group, a model group and a SYD group. The high-fat + high-salt method was used to induce PHT and excessive phlegm-dampness syndrome in the model and SYD rats. Different doses of SYD were used as an intervention over 8 weeks. Food consumption, weight, height, blood lipid and blood pressure were recorded for each group. The results show that, compared with the model group, the diet, weight and blood pressure of rats in SYD group decreased. Metabolites in the hypothalamus which differed in their expression between the three groups were identified and analyzed by LC-MS and the metabolic pathways were then determined. Fourteen metabolites in the hypothalamus were down-regulated and were mainly related to amino acid metabolism, glutathione metabolism, sphingolipid metabolism and glyceride metabolism, suggesting that SYD might alter hypothalamic dietary behavior, thereby affecting amino acid metabolism and energy metabolism. This study was approved by the Animal Ethics Review Committee of Shandong University of Traditional Chinese Medicine (approval number: SDUTCM20211103001).

     

/

返回文章
返回